Ad-hoc | 22 February 2007 07:28
Fresenius Medical Care AG & Co. KGaA / Final Results
Ad hoc announcement according to § 15 WpHG transmitted by DGAP - a company
of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Fresenius Medical Care Reports Full Year 2006 Results
Net revenue of Fresenius Medical Care AG & Co. KGaA ('the Company') was
$8,499 million, up 26% compared to 2005. Adjusted for currency, net revenue
rose 25%.
Operating income (EBIT) increased by 40% to $1,318 million. Excluding costs
related to the change of accounting principles for stock options (SFAS
123R) and one-time items, the operating income increased by 38% to $1,329
million
For the full year 2006, net income was $537 million, up 18% from 2005.
Excluding costs related to SFAS 123R and one-time items, net income for
2006 increased by 24% to $584 million.
For the tenth consecutive year, shareholders can expect to receive an
increased annual dividend. At the Annual General Meeting to be held on May
15, 2007, shareholders will be asked to approve a dividend per ordinary
share of €1.41, an increase of 15% (2005: €1.23).
For the full year 2007, the Company expects to achieve revenue of
approximately $9.4 billion, an increase of 11%. The net income is expected
to be between $675 million and $695 million in 2007. This represents an
increase of between 18% and 21% on an adjusted basis to 2006. On a reported
basis, the net income would increase by 26% to 29%. The Company expects
capital expenditures and spending on acquisitions to be approximately
$650 million.
Fresenius AG (WKN 578560, 578563) holds approximately 36% of Fresenius
Medical Care AG & Co. KGaA’s capital.
Fresenius Medical Care AG & Co. KGaA,
Represented by Fresenius Medical Care Management AG,
Board of Management,
Bad Homburg v.d.H., February 22, 2007
DGAP 22.02.2007
----------------------------------------------------------------------
Language: English
Issuer: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg Deutschland
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: ir@fmc-ag.com
WWW: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in
Berlin-Bremen, Hannover, München, Hamburg, Düsseldorf,
Stuttgart; Terminbörse EUREX; Foreign Exchange(s) NYSE
End of News DGAP News-Service
---------------------------------------------------------------------------